Three proposed transactions just picked up the sort of legal glare boards hate seeing. A shareholder-rights firm, Halper Sadeh, said on November 18, 2026 that it is investigating whether the deals involving Greenland Energy, Rapid Micro Biosystems and Aytu BioPharma may involve federal securities-law violations or breaches of fiduciary duty. That is an allegation worth watching, not a verdict, and investors ought to keep that distinction nailed to the wall.
Different Deal Shapes, Same Old Questions
The three situations are not interchangeable. Greenland Energy Company, NASDAQ:GLND, is pursuing a merger with 80 Mile plc, with Greenland holders expected to own roughly 50% of the combined company once the transaction closes. That makes this less of a clean cash-out argument and more of a debate over relative ownership, future assets, governance and who winds up carrying the risk after the corporate paperwork is done.
Rapid Micro Biosystems, NASDAQ:RPID, is set to be sold to Merck KGaA, Darmstadt, Germany for $0.75 per share. Aytu BioPharma, NASDAQ:AYTU, is set to be sold to Rosemont Pharmaceuticals Holdings for $2.70 per share. Cash-per-share deals look wonderfully simple until shareholders ask the question that actually matters: simple compared with what? The announcement does not supply valuation analyses, prior bids, board-process details or fairness opinions. That leaves plenty of blanks, and blanks are where merger disputes tend to breed.
Price Is Only One Piece of the Mess
Halper Sadeh says the proposed transactions may include terms that limit superior competing offers. That is the pressure point. Deal protections can be sensible; buyers generally do not spend time and money negotiating a transaction only to be used as a free auction paddle. But there is a line between protecting a legitimate agreement and boxing shareholders into a deal before the market gets a fair chance to speak.
Investors should want clear answers on any no-shop provisions, termination fees, matching rights or other mechanisms that could deter another bidder. None of those specific provisions are identified in the notice, so nobody should pretend they have already spotted a smoking gun. Still, when a law firm flags possible limits on better offers, the proxy materials and merger agreement deserve closer reading than the usual skim-and-click routine.
“Potential” is doing a lot of work here: a review has been announced, while the underlying claims have not been proven.
Insider Benefits Need Daylight, Not Guesswork
The firm also says insiders may receive substantial financial benefits unavailable to ordinary shareholders. Again, the notice does not quantify those benefits or identify which executives or directors may receive them. That matters. Change-in-control payments, equity acceleration, retained roles, rollover arrangements and other side benefits are not automatically improper. Plenty are disclosed and legitimately negotiated. Yet they can muddy a board’s incentives when public holders are being asked to surrender their shares at a fixed price.
For Greenland holders, the 50% ownership figure is particularly important because the post-merger picture will matter as much as the signing-day headline. Who controls the combined board? What assets and liabilities are being combined? How is the exchange ratio justified? Those are not academic footnotes. In a stock-for-stock merger, they are the deal.
What Shareholders Can Actually Watch
- Read the eventual proxy or other transaction disclosure for the board’s rationale and financial analyses.
- Compare any disclosed insider compensation or rollover terms with what common shareholders receive.
- Look for competing-bid restrictions and the size and structure of any breakup fee.
- Track voting deadlines, closing conditions and amendments rather than assuming the announced terms are the final terms.
Halper Sadeh says it may seek increased consideration, additional disclosures, information, or other relief for shareholders. It also says it will discuss rights and options without cost or obligation and would handle matters on a contingent-fee basis, meaning clients would not be responsible for out-of-pocket legal fees or expenses under that arrangement. That is the firm’s stated pitch, not a prediction that recovery or a revised deal is coming.
One minor bit of sloppiness in the materials is worth noting: the announcement identifies Halper Sadeh as an LLC, while its source line uses LLP. That may be nothing more than a naming inconsistency, but merger claims are built on details, and companies asking investors to approve a transaction should expect the same fussy attention. For holders of GLND, RPID and AYTU, the practical lesson is plain: do not confuse a signed deal with a fully examined deal.